Marc Martin
Preclinical and Regulatory Strategy Director
PhD in pharmacology with over 20 years of experience in the scientific, regulatory, and clinical development of health products, Marc has held senior leadership roles across regulatory authorities and innovation-focused environments.
He has played a key role in shaping authorization, early access, and innovation pathways for medicines at both national and European levels.
Before joining ILife Consulting, Marc held senior positions at the French Health Products Agency, where he led regulatory strategy, benefit–risk assessment, and early access programs for innovative therapies.
​
His current responsibilities include:
-
Supporting biotech and medtech companies in regulatory and development strategy
-
Advising on preclinical and clinical development plans
-
Guiding interactions with regulatory authorities at national and European levels
-
Contributing to benefit–risk assessment and access strategies for innovative products
Experience
-
Regulatory strategy for innovative medicines and advanced therapies
-
Early access and accelerated regulatory pathways
-
Benefit–risk assessment across multiple therapeutic areas
-
Infectious transmission risk assessment for healthcare products
-
Scientific and regulatory support from early development to clinical stages